This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Engagements

TEVA/Mylan

Charles River Associates Yellow Pill Production Line

TEVA announced on July 27th its intention to withdraw its unsolicited expression of interest to acquire rival Mylan N.V., a leading global pharmaceutical company with a growing portfolio of around 1,400 generic pharmaceuticals and brand medications.

Meet our team

Related insights

Explore our thinking

Upcoming events

See all events